Zhoufeng Wang,Kailing Tu,Lin Xia,Kai Luo,Wenxin Luo,Jie Tang,Keying Lu,Xinlei Hu,Yijing He,Wenliang Qiao,Yongzhao Zhou,Jun Zhang,Feng Cao,Shuiping Dai,Panwen Tian,Ye Wang,Lunxu Liu,Guowei Che,Qinghua Zhou,Dan Xie,Weimin Li

Abstract:<p>SF1:Table S1. The Clinical information and pathologic characteristics of 47 NSCLC patients and 4 non-malignant nodules patients; SF2:Table S2. Information of DNA-seq, RNA-seq, ATAC-seq and single-cell ATAC-seq; SF3:Table S3. Significant amplication and deletion regions of LUAD and LUSC samples (Genes marked in red were known cancer genes); SF4:Table S4. GREAT enrichment of common open regions; SF5:Table S5. Expression change of cluster II specific open peak related genes. SF6:Table S6. Sample Information and classification; SF7:Table S7. Sub cluster 2 specific region GREAT enrichment; SF8:Table S8. broad open chromatin region related genes; SF9:Table S9. sCOP and their accosiated DEGs; SF10:Table S10. Known important NSCLC related genes were affected by sCOP; SF11:Table S11. Joint-QTLs and Genes; SF12:Table S12. Haplotype blocks harboring both joint-QTL and GWAS lead SNP of lung cancer;</p>

Supplementary Materials 3 from Characterizing the Molecular Spatial and Temporal Field of Injury in Early-Stage Smoker Non–Small Cell Lung Cancer Patients after Definitive Surgery by Expression Profiling

Supplementary Materials 2 from Characterizing the Molecular Spatial and Temporal Field of Injury in Early-Stage Smoker Non–Small Cell Lung Cancer Patients after Definitive Surgery by Expression Profiling

Supplementary Figures 1 - 3 from Characterizing the Molecular Spatial and Temporal Field of Injury in Early-Stage Smoker Non–Small Cell Lung Cancer Patients after Definitive Surgery by Expression Profiling

Supplementary Table 1 from Characterizing the Molecular Spatial and Temporal Field of Injury in Early-Stage Smoker Non–Small Cell Lung Cancer Patients after Definitive Surgery by Expression Profiling

Supplementary Table 2 from Proteomic Profiling Identifies Dysregulated Pathways in Small Cell Lung Cancer and Novel Therapeutic Targets Including PARP1

Supplementary Table 7 from Proteomic Profiling Identifies Dysregulated Pathways in Small Cell Lung Cancer and Novel Therapeutic Targets Including PARP1

Supplementary Table 4 from Proteomic Profiling Identifies Dysregulated Pathways in Small Cell Lung Cancer and Novel Therapeutic Targets Including PARP1

Supplementary Figure 3 from Proteomic Profiling Identifies Dysregulated Pathways in Small Cell Lung Cancer and Novel Therapeutic Targets Including PARP1

Supplementary Table 1 from Multistage Analysis of Variants in the Inflammation Pathway and Lung Cancer Risk in Smokers

Supplementary Fig S21-S24 from Resolving the Spatial and Cellular Architecture of Lung Adenocarcinoma by Multiregion Single-Cell Sequencing

Supplementary Materials from Targeting DNA Damage Response Promotes Antitumor Immunity Through STING-Mediated T-cell Activation in Small Cell Lung Cancer

Supplementary Figures S1-S21 from Integrated Multi-Omics Analysis of Early Lung Adenocarcinoma Links Tumor Biological Features with Predicted Indolence or Aggressiveness

Supplementary Text from CXCR2 Expression in Tumor Cells Is a Poor Prognostic Factor and Promotes Invasion and Metastasis in Lung Adenocarcinoma

Supplementary Tables 1 - 3 from Predictors of Survival in Never-Smokers with Non–Small Cell Lung Cancer: A Large-Scale, Two-Phase Genetic Study

Supplementary Tables 1 - 3 from Pathway-Based Serum microRNA Profiling and Survival in Patients with Advanced Stage Non–Small Cell Lung Cancer

Supplementary Tables from The Open Chromatin Landscape of Non–Small Cell Lung Carcinoma

Supplementary Figure 2 from the Use of Quantitative Real-Time Reverse Transcriptase PCR for 5′ and 3′ Portions of <i>alk</i> Transcripts to Detect <i>alk</i> Rearrangements in Lung Cancers

Supplementary Methods and Material from The Open Chromatin Landscape of Non–Small Cell Lung Carcinoma

Supplementary Data from Identification of Active Bronchioalveolar Stem Cells as the Cell of Origin in Lung Adenocarcinoma

Supplementary Data 1 from Prostate Cancer in World Trade Center Responders Demonstrates Evidence of an Inflammatory Cascade

Supplementary Text from Integrative Genomic Characterization of Oral Squamous Cell Carcinoma Identifies Frequent Somatic Drivers